MIR106B and pancreatic adenocarcinoma: CASKIN2, TLE2, USP20, SPRN, ARSG, MIR106B, and MIR98 were considered to be substantially expressed in the low-risk group, suggesting that these genes may be PAAD tumor suppressor genes.